Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-04-26

Clinical Trial Update: Pretarsal Versus Preseptal Botulinum Toxin for Patients With Eyelid Spasm [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing pretarsal vs preseptal botulinum toxin for eyelid spasm has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botulinum toxins, Type A (botulinum toxin type A)

Snippet

Sponsor: The University of Hong Kong | Conditions: Blepharospasm, Hemifacial Spasm | Phase 4 | Status: COMPLETED